| Date Filed | Type | Description |
| 01/18/2023 |
4
| Williams Lewis T (Director) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Granted 30,000 options to buy
@ $12.17, valued at
$365.1k
|
|
| 05/27/2022 |
4
| Williams Lewis T (Director) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Granted 20,000 options to buy
@ $8.31, valued at
$166.2k
|
|
| 02/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2022 |
3
| Williams Lewis T (Director) has filed a Form 3 on Arcellx, Inc. |
| 05/28/2021 |
4
| Williams Lewis T (Director) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Granted 18,000 options to buy
@ $35.23, valued at
$634.1k
|
|
| 05/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/29/2020 |
4
| Williams Lewis T (Director) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Granted 15,000 options to buy
@ $16.54, valued at
$248.1k
|
|
| 05/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/15/2019 |
4
| Williams Lewis T (Director) has filed a Form 4 on Neoleukin Therapeutics, Inc.|
Txns:
| Granted 22,000 options to buy
@ $2.82, valued at
$62k
|
|
| 09/04/2019 |
4
| Williams Lewis T (Director) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 7,024 shares
@ $5.43, valued at
$38.1k
|
|
| 08/12/2019 |
3
| Williams Lewis T (Director) has filed a Form 3 on Neoleukin Therapeutics, Inc. |
| 06/12/2019 |
4
| Williams Lewis T (Director) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC|
Txns:
| Granted 15,000 options to buy
@ $6.09, valued at
$91.4k
|
|
| 06/11/2019 |
4
| Williams Lewis T (Director) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Granted 12,000 options to buy
@ $11.8, valued at
$141.6k
|
|
| 02/28/2019 |
4/A
| Williams Lewis T (Director) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC|
Txns:
| Granted 1,000 shares
@ $0
Granted 6,400 options to buy
@ $11.97, valued at
$76.6k
|
|
| 02/27/2019 |
4
| Williams Lewis T (Director) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC|
Txns:
| Paid exercise price by delivering 926 shares
@ $11.95, valued at
$11.1k
|
|
| 02/07/2019 |
4
| Williams Lewis T (Director) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC|
Txns:
| Paid exercise price by delivering 3,144 shares
@ $11.43, valued at
$35.9k
|
|
| 11/13/2018 |
4
| Williams Lewis T (Executive Chairman) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC|
Txns:
| Exercised 91,217 options to buy
@ $4.56, valued at
$415.9k
|
|
| 09/05/2018 |
4
| Williams Lewis T (Executive Chairman) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC|
Txns:
| Paid exercise price by delivering 7,024 shares
@ $14, valued at
$98.3k
|
|
| 06/12/2018 |
4
| Williams Lewis T (Director) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Granted 12,000 options to buy
@ $6.98, valued at
$83.8k
|
|
| 02/28/2018 |
4
| Williams Lewis T (Executive Chairman) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC|
Txns:
| Granted 5,000 shares
@ $0
Granted 30,000 options to buy
@ $18.69, valued at
$560.7k
|
|
| 02/13/2018 |
4/A
| Williams Lewis T (Executive Chairman) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC |
| 02/13/2018 |
4/A
| Williams Lewis T (Executive Chairman) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC|
Txns:
| Paid exercise price by delivering 32,613 shares
@ $44.74, valued at
$1.5M
Gifted 22,416 shares
@ $0 |
|
| 02/07/2018 |
4
| Williams Lewis T (Executive Chairman) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC|
Txns:
| Paid exercise price by delivering 3,137 shares
@ $18.42, valued at
$57.8k
|
|
| 09/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2017 |
4
| Williams Lewis T (Director) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Granted 24,000 options to buy
@ $10.84, valued at
$260.2k
|
|
| 06/08/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 03/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/09/2017 |
4
| Williams Lewis T (President, CEO and Chairman) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC |
| 01/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/23/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/15/2016 |
4
| Williams Lewis T (President, CEO and Chairman) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC|
Txns:
| Gifted 407 shares
@ $0 |
|
| 09/01/2016 |
4
| Williams Lewis T (President, CEO and Chairman) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC|
Txns:
| Paid exercise price by delivering 7,613 shares
@ $44.74, valued at
$340.6k
Gifted 22,416 shares
@ $44.74, valued at
$1M
|
|
| 08/29/2016 |
4
| Williams Lewis T (President, CEO and Chairman) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC|
Txns:
| Granted 42,500 shares
@ $0
Granted 180,000 options to buy
@ $43.71, valued at
$7.9M
|
|
| 05/13/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|